Untitled - Media Med Publicis

40 / Grupul de lucru de Ateroscleroză
17. Cockcroft JR. Exploring vascular benefi ts of endothelium-derived nitric oxide. Am J
Hypertens 2005; 18: 177-183.
18. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. A marker of atherosclerotic
risk. Arterioscler Thromb Vasc Biol 2003; 23: 168-175.
19. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular disease: the role of
oxidant stress. Circ Res 2000; 87: 840-844.
20. Maadamanchi NR, Vendrov A, Runge MS. Oxidative stress and cardiac disease. Arteriosler
Thromb Vasc Biol 2005; 25: 29-38.
21. Hansson GK. Infl ammation, atheroslerosis and coronary artery disease. N Engl J Med
2005; 352: 1685-1695.
22. Willkinson IB, Franklin SS, Cockcroft JR. Nitric Oxide and the regulation of large
artery stiffness. Hypertension 2004; 44: 112-116.
23. Behrendt D, Ganz P. Endothelial function: from vascular biology to clinical applications.
Am J Cardiol 2002; 90: 40-48.
24. Poredos P. Endothelial dysfunction and cardiovascular disease. Pathophysiol Haemost
Thromb 2002; 32: 274-277.
25. Loscalzo J. Nitric Oxide insuffi ciency, platelet activation and arterial thrombosis. Circ
Res 2001; 88: 756-762.
26. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine
in atherosclerotic coronary arteries. N Engl J Med 1986, 315: 1046-1051.
27. Anderson TJ, Gerhard MD, Meredith IT, et al. Systemic nature of endothelial dysfunction
in atherosclerosis. Am J Cardiol 1995; 75: 71-74.
28. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of
vas cular disease. Circulation 2003; 108: 2054-2059.
29. Tousoulis D, Antoniades C, Stefanadis C. Evaluating endothelial function in humans: a
guide to invasive and non-invasive techniques. Heart 2005; 91: 553-558.
30. Deanfi eld J, Donnald A, Ferri C, et al. Endothelial function and dysfunction. Part I:
Metho dological issues for assessment in the different vascular beds: A statement by
the Working Group on Endothelin and Endothelial Factors of the European Society of
Hyper tension. J Hypertens 2005; 23: 7-17.
31. Cohn JN, Quyyumi AA, Hollenberg NK, et al. Surrogate markers for cardiovascular
disease. Functional markers. Circulation 2004; 109: 31-46.
32. Quyyumi AA. Endothelial function in health and disease: new insights into genesis of
cardiovascular disease. Am J Med 1998; 105: 32-39.
33. Quyyumi AA, Dakak N, Andrewes NP. Nitric Oxide activity in the human coronary and
peripheral circulations. J Am Coll Cardiol 1995; 95: 1747-1755.
34. Tousoulis D, Davies G, Lefroy DC. Variable coronary vasomotor responses to acetylcholine
in patients with normal coronary arteriograms: evidence for localized endothelial
dysfunction. Heart 1996; 75: 261-266.
35. Doucette JW, Corl PD, Payne HM. Validation of Doppler guide wire for intravascular
measurement of coronary artery fl ow velocity. Circulation 1992; 85: 1899-1911.
36. Anderson AJ, Uehata A, Gerhard MD. Close relation of endothelial function in the
human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26: 1235-1241.
37. Kuvin JT, Patel AR, Sliney KA, et al. Peripheral vascular endothelial function testing as
a noninvasive indicator of coronary artery disease. J Am Coll Cardiol 2001; 38: 1843-
1849.
38. Taddei S, Viridis A, Ghiadoni L, et al. Vitamin C improves endothelium-dependent
vaso di latation by restoring nitric oxide activity in essential hypertension. Circulation
1988; 97: 2222-2229.